Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
AMGN | Amgen, Inc. | 1.17% | 246.35 | 1.5% | $948.15m | |
MRNA | Moderna, Inc. | 0.11% | 142.35 | 0.0% | $806.78m | |
REGN | Regeneron Pharmaceuticals, Inc. | 1.40% | 602.72 | 2.6% | $519.19m | |
VRTX | Vertex Pharmaceuticals, Inc. | 2.17% | 282.17 | 1.9% | $512.67m | |
GILD | Gilead Sciences, Inc. | 0.48% | 62.51 | 1.0% | $510.20m | |
NVAX | Novavax, Inc. | 1.28% | 51.72 | 75.7% | $422.53m | |
ILMN | Illumina, Inc. | -0.88% | 185.78 | 3.3% | $354.39m | |
BIIB | Biogen, Inc. | 1.35% | 205.24 | 1.8% | $245.45m | |
SNSS | Sunesis Pharmaceuticals, Inc. | 1.80% | 3.40 | 0.7% | $237.67m | |
CRSP | CRISPR Therapeutics AG | -0.40% | 63.03 | 0.6% | $169.22m | |
BNTX | BioNTech SE | 0.94% | 141.14 | 0.0% | $168.46m | |
BMRN | BioMarin Pharmaceutical, Inc. | 0.37% | 83.46 | 4.2% | $123.97m | |
EXAS | EXACT Sciences Corp. | -1.00% | 40.70 | 17.7% | $98.50m | |
IOVA | Iovance Biotherapeutics, Inc. | -2.14% | 10.75 | 0.0% | $93.65m | |
TECH | Bio-Techne Corp. | -0.18% | 345.39 | 4.5% | $93.05m |
Company Profile
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.